Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00134888 · ClinicalTrials.gov registry record · NA
Blockade Efficacy of Buprenorphine/Naloxone For Opioid Dependence
A NA study, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT00134888 is a NA study that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 8 participants.
The verdict
NCT00134888, a NA study, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
Buprenorphine, a treatment for opioid dependence, can be mixed with naloxone, to limit abuse potential. The purpose of this study is to examine the effectiveness of buprenorphine/naloxone that is given at less than daily intervals, in order to prevent withdrawal symptoms associated with stopping opioid abuse.
Interventions
- DRUG Buprenorphine/naloxone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2000-12 |
| Est. Completion | 2002-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00134888
The ClinicalTrials.gov registry entry for NCT00134888 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Buprenorphine/naloxone is the first listed.
NCT00134888 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00134888 about?
NCT00134888 is a clinical study titled "Blockade Efficacy of Buprenorphine/Naloxone For Opioid Dependence". Buprenorphine, a treatment for opioid dependence, can be mixed with naloxone, to limit abuse potential. The purpose of this study is to examine the effectiveness of buprenorphine/naloxone that is given at less than daily intervals, in order to prevent withdrawal symptoms associated with stopping opi...
What is the current status of trial NCT00134888?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2000-12. Estimated completion is 2002-11.
What interventions are being tested in trial NCT00134888?
The interventions under investigation include: Buprenorphine/naloxone (DRUG).
Who is sponsoring clinical trial NCT00134888?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.